Support members with rare diseases We help members navigate rare diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management Rare diseases Learn more...

See our history Our teams have poured energy, integrity and compassion into transforming pharmacy solutions, turning barriers into breakthroughs. Breadcrumb Home Who we are Our history Tab 1 2021 –...

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

Prime’s Special Investigations Unit is specially trained to protect patients and providers throughout the health care continuum

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars

publications Trending Topics & Drug Approvals: May 2025 Your source for the latest drug information highlights June 4, 2025 Trending Topics Hot topics The United States (U.S.) Food and Drug...

Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

oncology insights Oncology Insights: 2024 Rewind January 16, 2025 Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 High Cost Therapy Profile Oncology Imetelstat Intravenous (IV) Geron Proposed...

publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...

Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...

Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics

Cover image for FDA Decisions Expected November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...

publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...

See our award-winning people & work Prime delivers unmatched care, groundbreaking research and industry-leading programs and services for health plans, employers and members. Breadcrumb Home Who we...

Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 Neurology Eladocagene Exuparvovec Intrapuraminal PTC Therapeutics, Inc. Proposed indications...

Tap into predictive analytics Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and prescriptive analytics....

Get support from the specialists in specialty We provide end-to-end support for patients taking specialty meds, helping them navigate the care journey. Breadcrumb Home Pharmacy Specialty Pharmacy...

Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab August 15, 2024 High Cost Therapy Profile Oncology Linvoseltamab, intravenous (IV) Regeneron...

These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.

Comprehensive PDL services With 40+ years of Medicaid pharmacy experience supporting over half the nation’s programs, we help states manage high drug costs and ensure members get the meds they...

Experience a different kind of PBM We’re your trusted, transparent partner that’s reimagining pharmacy solutions to deliver value back to those we serve and transforming our industry for the...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Event will feature David Lassen, chief clinical officer

Annual conference features presentations, panels, discussions and networking

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Breadcrumb Home Newsroom Custom Content Publications High-Cost Therapy Profile: September 2024 PUBLIcATIonS High-Cost Therapy Profile: September 2024 Detailed information about Intravenous (IV)...

Dinesh Kandanchatha joined the organization July 1.

PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...

Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...

Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...

Managed Markets Insight & Technology (MMIT)

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey